Download Sample
Loading...
| A02366 | Pages: 277 | Jul 2021 | 5469 Views | | |
| Author(s) : Trupti Wadekar, Linu Dash , Onkar Sumant | Tables: 149 | Charts: 42 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Bioreactors Market
Request Now !bioreactors market was valued at $2,615.4 million in 2020, and is estimated to reach $7,328.4 million by 2030, growing at a CAGR of 10.7% from 2021 to 2030.
The COVID-19 outbreak is anticipated to have a positive impact on the growth of the global bioreactors market. The COVID-19 pandemic has stressed healthcare system in the world and increased the need for vaccine and monoclonal antibodies for the prevention and treatment of patients suffering from corona virus. A huge number of researches were conducted in cell culture medium that are grown in bioreactors.
Bioreactors are defined as a manufacturing device or vessel in which biological reactions are performed and are used to grow various organisms such as yeast, bacteria, or animal cell under appropriate environment. They maintain a sustainable environment for cell growth and product formation. Bioreactors are used in pharmaceutical and biotechnology industry in order to produce vaccines, antibodies or biologic products. They are also used in industrial process in order to cultivate organism under controlled condition and produce pharmaceutical products for treatment of chronic disease.
Get more information on this report : Request Sample Pages
Growth of the global bioreactors market is majorly driven by an increase in demand for monoclonal antibiotics; rise in funding from private & government organizations for development of vaccine; surge in demand for single-use bioreactors; and increase in development in the pharmaceutical and biotechnology industry. For instance, in 2019, Applikon Biotechnology, a manufacturing company specialized in upstream bioprocess equipment, launched single use AppliFlex ST lab-scale bioreactor, which is a fully customized single use bioreactor, and is provided with pre sterilized and “ready to go” system in order to save time while cell culture set up. In addition, rise in technological development for advanced bioreactor and advancement in equipment design for bioprocessing fuels the bioreactors market growth during the forecast period. Moreover, in 2021, Beckman Coulter Life Science, a Danaher corporation engaged in healthcare development, launched new BioLector XT Microbioreactor, which enable high-throughput strain screening, feeding strategy optimization and monitoring of cultivation parameters. It also possesses the ability to collect high quality data in short span of time by the use of least amount of manual mechanism.
Thus, presence of key players in manufacturing of advanced bioreactors, rise in R&D activities for cell culture and microbial application and increase in number of clinical and pre-clinical trial study, surge the demand for bioreactors and propel the growth of the market. However, high cost associated with bioreactors is expected to restrict the bioreactors market growth during the forecast period.
The bioreactors market is segmented on the basis of type, usage, scale, control type and region. By type, the market is categorized into glass, stainless steel, and single-use.
By usage, the market is divided into lab-scale production, pilot-scale production, and full-scale production. On the basis of scale, the market is classified into 5L-20L, 20L-200L, 200L-1500L and above 1500L. By control type, the market is fragmented into manual and automated (MFCs).
Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Depending on type, the single use segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in demand for biologic drugs, initiatives taken by the government for the development of the pharmaceutical sector and advancement in R&D activities for production of vaccine. However, the glass segment is expected to witness considerable market growth during the forecast period, due to surge in demand for monoclonal antibiotics, advancement in technology for advanced bioreactor and increase in funding for biotechnological segments.
Get more information on this report : Request Sample Pages
On the basis of usage, the pilot-scale production segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of chronic disease, development in pharmaceutical and biotechnology industry and increase in number for clinical and pre-clinical trial study. However, the full-scale production segment is expected to witness considerable growth during the forecast period, owing to advancement in R&D activities for vaccine development and surge in adoption of advanced bioreactors.
Get more information on this report : Request Sample Pages
On the basis of control type, the automated segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of chronic disease, surge in adoption of cell culture technique and advancement in R&D activities for the production of personalized medicine. However, the manual segment is expected to witness considerable growth during the forecast period, owing to increase in prevalence of chronic disease, growth in the pharmaceutical industry for cell culture application, and increase in number of unemployment.
Get more information on this report : Request Sample Pages
North America accounted for a major share in the bioreactors market in 2020, and is expected to maintain its dominance during the forecast period, owing to rise in prevalence of chronic diseases, the presence of key players in manufacturing advanced bioreactors, and advancements in R&D in biomedical research in the region. However, Asia-Pacific is expected to register highest CAGR of 12.3% from 2021 to 2030, owing to increase in prevalence of chronic diseases, increase in demand for novel biologic drugs, and rise in number of pharmaceutical industry.
Get more information on this report : Request Sample Pages
Key players operating in the global bioreactors market include BBI-Biotech GmbH, Bioengineering AG, Danaher Corporation, Eppendorf AG, Getinge, Infors HT, Merck KGAA, Sartorius AG, Solaris Biotech Solutions, and Thermo Fisher Scientific, Inc.
Key Benefits For Stakeholders
Key Market Segments
By Type
By Usage
By Scale
By Control Type
By Region
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Advancements in R&D activities for novel biologic and microbial application
3.5.1.2.Rise in technological development for advanced bioreactors
3.5.1.3.Increase in demand for single-use bioreactors
3.5.2.Restraint
3.5.2.1.High cost of bioreactors
3.5.3.Opportunity
3.5.3.1.Increase in the development of biotechnology and pharmaceutical industry
3.5.4.Impact analysis
3.6.Impact analysis of COVID-19 on the bioreactors market
CHAPTER 4:BIOREACTORS MARKET , BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Single-Use
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Stainless Steel
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Glass
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:BIOREACTORS MARKET , BY USAGE
5.1.Overview
5.1.1.Market size and forecast
5.2.Pilot-Scale Production
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Full-Scale Production
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country
5.4.Lab-Scale Production
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country
CHAPTER 6:BIOREACTORS MARKET , BY SCALE
6.1.Overview
6.1.1.Market size and forecast
6.2.5L-20L
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country
6.3.20L-200L
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country
6.4.200L-1500L
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country
6.5.Above 1500L
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by region
6.5.3.Market analysis, by country
CHAPTER 7:BIOREACTORS MARKET , BY CONTROL TYPE
7.1.Overview
7.1.1.Market size and forecast
7.2.Automated
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by region
7.2.3.Market analysis, by country
7.3.Manual
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by region
7.3.3.Market analysis, by country
CHAPTER 8:BIOREACTORS MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends, growth factors, and opportunities
8.2.2.North America bioreactors market, by type
8.2.3.North America bioreactors market, by usage
8.2.4.North America bioreactors market, by scale
8.2.5.North America bioreactors market, by control type
8.2.6.Market size and forecast, by country
8.2.6.1.U.S.
8.2.6.1.1.U.S. bioreactors market, by type
8.2.6.1.2.U.S. bioreactors market, by usage
8.2.6.1.3.U.S. bioreactors market, by scale
8.2.6.1.4.U.S. bioreactors market, by control type
8.2.6.2.Canada
8.2.6.2.1.Canada bioreactors market, by type
8.2.6.2.2.Canada bioreactors market, by usage
8.2.6.2.3.Canada bioreactors market, by scale
8.2.6.2.4.Canada bioreactors market, by control type
8.2.6.3.Mexico
8.2.6.3.1.Mexico bioreactors market, by type
8.2.6.3.2.Mexico bioreactors market, by usage
8.2.6.3.3.Mexico bioreactors market, by scale
8.2.6.3.4.Mexico bioreactors market, by control type
8.3.Europe
8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Europe bioreactors market, by type
8.3.3.Europe bioreactors market, by usage
8.3.4.Europe bioreactors market, by scale
8.3.5.Europe bioreactors market, by control type
8.3.6.Market size and forecast, by country
8.3.6.1.Germany
8.3.6.1.1.Germany bioreactors market, by type
8.3.6.1.2.Germany bioreactors market, by usage
8.3.6.1.3.Germany bioreactors market, by scale
8.3.6.1.4.Germany bioreactors market, by control type
8.3.6.2.France
8.3.6.2.1.France bioreactors market, by type
8.3.6.2.2.France bioreactors market, by usage
8.3.6.2.3.France bioreactors market, by scale
8.3.6.2.4.France bioreactors market, by control type
8.3.6.3.UK
8.3.6.3.1.UK bioreactors market, by type
8.3.6.3.2.UK bioreactors market, by usage
8.3.6.3.3.UK bioreactors market, by scale
8.3.6.3.4.UK bioreactors market, by control type
8.3.6.4.Italy
8.3.6.4.1.Italy bioreactors market, by type
8.3.6.4.2.Italy bioreactors market, by usage
8.3.6.4.3.Italy bioreactors market, by scale
8.3.6.4.4.Italy bioreactors market, by control type
8.3.6.5.Spain
8.3.6.5.1.Spain bioreactors market, by type
8.3.6.5.2.Spain bioreactors market, by usage
8.3.6.5.3.Spain bioreactors market, by scale
8.3.6.5.4.Spain bioreactors market, by control type
8.3.6.6.Rest of Europe
8.3.6.6.1.Rest of Europe bioreactors market, by type
8.3.6.6.2.Rest of Europe bioreactors market, by usage
8.3.6.6.3.Rest of Europe bioreactors market, by scale
8.3.6.6.4.Rest of Europe bioreactors market, by control type
8.4.Asia-Pacific
8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Asia-Pacific bioreactors market, by type
8.4.3.Asia-Pacific bioreactors market, by usage
8.4.4.Asia-Pacific bioreactors market, by scale
8.4.5.Asia-Pacific bioreactors market, by control type
8.4.6.Market size and forecast, by country
8.4.6.1.China
8.4.6.1.1.China bioreactors market, by type
8.4.6.1.2.China bioreactors market, by usage
8.4.6.1.3.China bioreactors market, by scale
8.4.6.1.4.China bioreactors market, by control type
8.4.6.2.Japan
8.4.6.2.1.Japan bioreactors market, by type
8.4.6.2.2.Japan bioreactors market, by usage
8.4.6.2.3.Japan bioreactors market, by scale
8.4.6.2.4.Japan bioreactors market, by control type
8.4.6.3.India
8.4.6.3.1.India bioreactors market, by type
8.4.6.3.2.India bioreactors market, by usage
8.4.6.3.3.India bioreactors market, by scale
8.4.6.3.4.India bioreactors market, by control type
8.4.6.4.Australia
8.4.6.4.1.Australia bioreactors market, by type
8.4.6.4.2.Australia bioreactors market, by usage
8.4.6.4.3.Australia bioreactors market, by scale
8.4.6.4.4.Australia bioreactors market, by control type
8.4.6.5.South Korea
8.4.6.5.1.South Korea bioreactors market, by type
8.4.6.5.2.South Korea. bioreactors market, by usage
8.4.6.5.3.South Korea bioreactors market, by scale
8.4.6.5.4.South Korea bioreactors market, by control type
8.4.6.6.Rest of Asia-Pacific
8.4.6.6.1.Rest of Asia-Pacific bioreactors market, by type
8.4.6.6.2.Rest of Asia-Pacific bioreactors market, by usage
8.4.6.6.3.Rest of Asia-Pacific bioreactors market, by scale
8.4.6.6.4.Rest of Asia-Pacific bioreactors market, by control type
8.5.LAMEA
8.5.1.Key market trends, growth factors, and opportunities
8.5.2.LAMEA bioreactors market, by type
8.5.3.LAMEA bioreactors market, by usage
8.5.4.LAMEA bioreactors market, by scale
8.5.5.LAMEA bioreactors market, by control type
8.5.6.Market size and forecast, by country
8.5.6.1.Brazil
8.5.6.1.1.Brazil bioreactors market, by type
8.5.6.1.2.Brazil bioreactors market, by usage
8.5.6.1.3.Brazil bioreactors market, by scale
8.5.6.1.4.Brazil bioreactors market, by control type
8.5.6.2.Saudi Arabia
8.5.6.2.1.Saudi Arabia bioreactors market, by type
8.5.6.2.2.Saudi Arabia bioreactors market, by usage
8.5.6.2.3.Saudi Arabia bioreactors market, by scale
8.5.6.2.4.Saudi Arabia bioreactors market, by control type
8.5.6.3.South Africa
8.5.6.3.1.South Africa bioreactors market, by type
8.5.6.3.2.South Africa bioreactors market, by usage
8.5.6.3.3.South Africa bioreactors market, by scale
8.5.6.3.4.South Africa bioreactors market, by control type
8.5.6.4.Rest of LAMEA
8.5.6.4.1.Rest of LAMEA bioreactors market, by type
8.5.6.4.2.Rest of LAMEA bioreactors market, by usage
8.5.6.4.3.Rest of LAMEA bioreactors market, by scale
8.5.6.4.4.Rest of LAMEA bioreactors market, by control type
CHAPTER 9:COMPANY PROFILES
9.1.BBI-BIOTECH GmbH
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.2.BIOENGINEERING AG.
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.3.DANAHER CORPORATION
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance
9.3.6.Key strategic moves and developments
9.4.EPPENDORF AG
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments
9.5.GETINGE
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.5.6.Key strategic moves and developments
9.6.INFORS HT
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Key strategic moves and developments
9.7.MERCK KGAA
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments
9.8.SARTORIUS AG
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments
9.9.SOLARIS BIOTECH SOLUTIONS
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.10.THERMO FISHER SCIENTIFIC, INC.
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
9.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02.BIOREACTORS MARKET FOR SINGLE-USE, BY REGION, 2020-2030 ($MILLION)
TABLE 03.BIOREACTORS MARKET FOR STAINLESS STEEL, BY REGION, 2020-2030 ($MILLION)
TABLE 04.BIOREACTORS MARKET FOR GLASS, BY REGION, 2020-2030 ($MILLION)
TABLE 05.GLOBAL BIOREACTORS MARKET , BY USAGE, 2020-2030 ($MILLION)
TABLE 06.BIOREACTORS MARKET FOR PILOT-SCALE PRODUCTION, BY REGION, 2020-2030 ($MILLION)
TABLE 07.BIOREACTORS MARKET FOR FULL-SCALE PRODUCTION, BY REGION, 2020-2030 ($MILLION)
TABLE 08.BIOREACTORS MARKET FOR LAB-SCALE PRODUCTION, BY REGION, 2020-2030 ($MILLION)
TABLE 09.GLOBAL BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 10.BIOREACTORS MARKET FOR 5L-20L, BY REGION, 2020-2030 ($MILLION)
TABLE 11.BIOREACTORS MARKET FOR 20L-200L, BY REGION, 2020-2030 ($MILLION)
TABLE 12.BIOREACTORS MARKET FOR 200L-1500L, BY REGION, 2020-2030 ($MILLION)
TABLE 13.BIOREACTORS MARKET FOR ABOVE 1500L, BY REGION, 2020-2030 ($MILLION)
TABLE 14.GLOBAL BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 15.BIOREACTORS MARKET FOR AUTOMATED, BY REGION, 2020-2030 ($MILLION)
TABLE 16.BIOREACTORS MARKET FOR MANUAL, BY REGION, 2020-2030 ($MILLION)
TABLE 17.BIOREACTORS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 19.NORTH AMERICA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 20.NORTH AMERICA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 21.NORTH AMERICA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 22.NORTH AMERICA BIOREACTORS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 23.U.S. BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 24.U.S. BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 25.U.S. BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 26.U.S. BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 27.CANADA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 28.CANADA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 29.CANADA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 30.CANADA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 31.MEXICO BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 32.MEXICO BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 33.MEXICO BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 34.MEXICO BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 35.EUROPE BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 36.EUROPE BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 37.EUROPE BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 38.EUROPE BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 39.EUROPE BIOREACTORS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 40.GERMANY BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 41.GERMANY BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 42.GERMANY BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 43.GERMANY BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 44.FRANCE BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 45.FRANCE BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 46.FRANCE BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 47.FRANCE BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 48.UK BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 49.UK BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 50.UK BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 51.UK BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 52.ITALY BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 53.ITALY BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 54.ITALY BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 55.ITALY BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 56.SPAIN BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 57.SPAIN BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 58.SPAIN BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 59.SPAIN BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 60.REST OF EUROPE BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 61.REST OF EUROPE BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 62.REST OF EUROPE BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 63.REST OF EUROPE BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 64.ASIA-PACIFIC BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 65.ASIA-PACIFIC BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 66.ASIA-PACIFIC BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 67.ASIA-PACIFIC BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 68.ASIA-PACIFIC BIOREACTORS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 69.CHINA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 70.CHINA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 71.CHINA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 72.CHINA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 73.JAPAN BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 74.JAPAN BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 75.JAPAN BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 76.JAPAN BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 77.INDIA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 78.INDIA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 79.INDIA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 80.INDIA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 81.AUSTRALIA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 82.AUSTRALIA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 83.AUSTRALIA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 84.AUSTRALIA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 85.SOUTH KOREA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 86.SOUTH KOREA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 87.SOUTH KOREA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 88.SOUTH KOREA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 89.REST OF ASIA-PACIFIC BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 90.REST OF ASIA-PACIFIC BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 91.REST OF ASIA-PACIFIC BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 92.REST OF ASIA-PACIFIC BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 93.LAMEA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 94.LAMEA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 95.LAMEA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 96.LAMEA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 97.LAMEA BIOREACTORS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 98.BRAZIL BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 99.BRAZIL BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 100.BRAZIL BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 101.BRAZIL BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 102.SAUDI ARABIA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 103.SAUDI ARABIA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 104.SAUDI ARABIA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 105.SAUDI ARABIA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 106.SOUTH AFRICA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 107.SOUTH AFRICA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 108.SOUTH AFRICA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 109.SOUTH AFRICA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 110.REST OF LAMEA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 111.REST OF LAMEA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 112.REST OF LAMEA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 113.BBI: COMPANY SNAPSHOT
TABLE 114.BBI: OPERATING SEGMENTS
TABLE 115.BBI: PRODUCT PORTFOLIO
TABLE 116.BIOENGINEERING: COMPANY SNAPSHOT
TABLE 117.BIOENGINEERING: OPERATING BUSINESS SEGMENTS
TABLE 118.BIOENGINEERING: PRODUCT PORTFOLIO
TABLE 119.DANAHER: COMPANY SNAPSHOT
TABLE 120.DANAHER: PRODUCT SEGMENTS
TABLE 121.DANAHER: PRODUCT PORTFOLIO
TABLE 122.DANAHER: KEY DEVELOPMENTS
TABLE 123.EPPENDORF: COMPANY SNAPSHOT
TABLE 124.EPPENDORF: OPERATING SEGMENTS
TABLE 125.EPPENDORF: PRODUCT PORTFOLIO
TABLE 126.EPPENDORF: KEY DEVELOPMENTS
TABLE 127.GETINGE: COMPANY SNAPSHOT
TABLE 128.GETINGE: OPERATING BUSINESS SEGMENTS
TABLE 129.GETINGE: PRODUCT PORTFOLIO
TABLE 130.GETINGE: KEY DEVELOPMENTS
TABLE 131.INFORS: COMPANY SNAPSHOT
TABLE 132.INFORS: OPERATING SEGMENTS
TABLE 133.INFORS: PRODUCT PORTFOLIO
TABLE 134.INFORS: KEY DEVELOPMENTS
TABLE 135.MERCK: COMPANY SNAPSHOT
TABLE 136.MERCK: OPERATING SEGMENTS
TABLE 137.MERCK: PRODUCT PORTFOLIO
TABLE 138.MERCK: KEY DEVELOPMENTS
TABLE 139.SARTORIUS: COMPANY SNAPSHOT
TABLE 140.SARTORIUS: PRODUCT SEGMENTS
TABLE 141.SARTORIUS: PRODUCT PORTFOLIO
TABLE 142.SARTORIUS: KEY DEVELOPMENTS
TABLE 143.SOLARIS: COMPANY SNAPSHOT
TABLE 144.SOLARIS: PRODUCT SEGMENTS
TABLE 145.SOLARIS: PRODUCT PORTFOLIO
TABLE 146.THERMO FISHER: COMPANY SNAPSHOT
TABLE 147.THERMO FISHER: OPERATING SEGMENTS
TABLE 148.THERMO FISHER: PRODUCT PORTFOLIO
TABLE 149.THERMO FISHER: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.BIOREACTORS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR SINGLE-USE, BY COUNTRY, 2020-2030 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR STAINLESS STEEL, BY COUNTRY, 2020-2030 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR GLASS, BY COUNTRY, 2020-2030 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR PILOT-SCALE PRODUCTION, BY COUNTRY, 2020-2030 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR FULL-SCALE PRODUCTION, BY COUNTRY, 2020-2030 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR LAB-SCALE PRODUCTION, BY COUNTRY, 2020-2030 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR 5L-20L, BY COUNTRY, 2020-2030 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR 20L-200L, BY COUNTRY, 2020-2030 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR 200L-1500L, BY COUNTRY, 2020-2030 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR ABOVE 1500, BY COUNTRY, 2020-2030 (%)
FIGURE 23.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR AUTOMATED, BY COUNTRY, 2020-2030 (%)
FIGURE 24.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR MANUAL, BY COUNTRY, 2020-2030 (%)
FIGURE 25.DANAHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 26.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 27.DANAHER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 28.EPPENDORF: NET SALES, 2018–2020 ($MILLION)
FIGURE 29.EPPENDORF: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 30.EPPENDORF: REVENUE SHARE BY REGION, 2020(%)
FIGURE 31.GETINGE: NET SALES, 2018–2020 ($MILLION)
FIGURE 32.GETINGE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33.GETINGE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 34.MERCK: NET SALES, 2018–2020 ($MILLION)
FIGURE 35.MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36.MERCK: REVENUE SHARE BY REGION, 2020(%)
FIGURE 37.SARTORIUS: NET SALES, 2018–2020 ($MILLION)
FIGURE 38.SARTORIUS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39.SARTORIUS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 40.THERMO FISHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 41.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42.THERMO FISHER: REVENUE SHARE BY REGION, 2020(%)
According to analyst perspective, the growth of the bioreactors market is attributed to factors such as technological advancements in R&D for development of vaccines; rise in prevalence of chronic diseases such as cancer, cystic fibrosis, and heart disease; increase in funds from private and government organizations for biomedical research, and surge in demand for monoclonal antibodies and personalized medicine. The bioreactors market gains interest of biotechnology & pharma companies, owing to surge in demand for vaccines and regenerative medicine. This leads to increase in adoption of bioreactors. Moreover, the market has gained high traction in biotechnology and pharmaceutical company in recent years as these devices are used in cell culture and microbial application.
Further, North America is expected to witness highest growth, in terms of revenue, owing to rise in prevalence of chronic diseases, the presence of key players, and advancements in R&D activities for vaccine development.
Asia-Pacific was the second-largest contributor to the market in 2020, and is expected to register fastest CAGR during the forecast period, owing to increase in prevalence of chronic diseases, rise in funds by private and government organization for biomedical research, increase in demand for novel drugs, and rise in number of pharmaceutical industry.
In addition, the high cost associated with bioreactors is anticipated to restrain the market growth during the forecast period.
A. The total market value of bioreactors Market is $2,615.4 million in 2020.
A. The forecast period in the report is from 2021 to 2030
A. The market value of bioreactors Market in 2021 was $2,932.4 million
A. The base year for the report is 2020.
A. Yes, bioreactors companies are profiled in the report
A. The top companies that hold the market share in bioreactors market are BBI-Biotech GmbH, Bioengineering AG, Danaher Corporation, Eppendorf AG, Getinge, Infors HT, Merck KGAA, Sartorius AG, Solaris Biotech Solutions, Thermo Fisher Scientific, Inc.
A. No, there is no value chain analysis provided in the bioreactors Market report
A. The key trends in the bioreactors Market are advancement in R&D for vaccine development, increase in prevalence of chronic disease, surge in demand for monoclonal antibiotics, and development of pharmaceutical and biotechnology industry.
Enterprise
License/PDF
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers